Nephrotoxicity of increased glomerular protein traffic

Nephrology Dialysis Transplantation

Volumn 14, Issue 2, 1999, Pages 304-312

  Abbate, Mauro ^a   Benigni, Ariela ^a   Bertani, Tullio ^a,b   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

DENDRITIC CELL; KIDNEY INJURY; KIDNEY TUBULE; MONOCYTE; NEPHRITIS; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN TRANSPORT; PROTEINURIA; REVIEW; T LYMPHOCYTE;

ANIMALS; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; NEPHRONS; PROTEINURIA;

EID: 0032919645     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.2.304     Document Type: Review

References (78)

1. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982; 307: 652-659
2. Remuzzi G. Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 1995; 4: 339-342
3. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2-15
4. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse respone to renal ablation. Am J Physiol 1981; 241: F85-93
5. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982; 22: 112-126
6. Wen S-F, Huang T-P, Moorthy AV. Effect of low-protein diet on experimental diabetic nephropathy in the rat. J Lab Clin Med 1985; 106: 589-597
7. Hostetter TH, Meyer TW, Rennke HG, Brenner BM. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 1986; 30: 509-517
8. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-619
9. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925-1930
10. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 1988; 82: 1757-1768
11. Gansevoort RT, Wapstrat FH, Weening JJ et al. Sodium depletion enhances the antiproteinuric effect of ace inhibition in established experimental nephrosis. Nephron 1992; 60: 246-247
12. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990; 85: 541-549
13. Zoja C, Corna D, Bruzzi I et al. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 1996; 4: 213-221
14. Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I. Role for angiotensin II in an overt functional proteinuria. Kidney Int 1986; 30: 538-545
15. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circ Res 1987; 61: 531-538
16. Brown DM, Steffes MW, Thibert P, Azar S, Mauer SM. Glomerular manifestations of diabetes in the BB rat. Metabolism 1983; 32: 131-135
17. Cohen AJ, McCarthy DM, Rossetti RG. Renin secretion of the spontaneously diabetic rat. Diabetes 1986; 35: 341-345
18. Bertani T, Zoja C, Abbate M, Rossini M, Remuzzi G. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein contents. Lab Invest 1989; 60: 196-204
19. Magil AB. Tubulointerstitial lesions in young Zucker rats. Am J Kidney Dis 1995; 25: 478-485
20. The Gisen Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349: 1857-1863
21. Peterson JC, Adler S, Burkart JM et al. Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med 1995; 123: 754-762
22. Breyer JA, Bain RP, Evans JK et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 1996; 50: 1651-1658
23. Ruggenenti P, Gaspari F, Perna A, Remuzzi G. Cross sectional longitudinal study of spot morning urine protein: creatinine ratio, 24 h urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. Br Med J 1998; 316: 504-509
24. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G. Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986; 30: 488-496
25. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394
26. Eddy AA, McCulloch L, Adams J, Liu E. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135: 719-733
27. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995; 47: 1546-1557
28. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature. Am J Kidney Dis 1992; 20: 315-323
29. Wehrmann M, Bohle A, Held H, Schumm G, Kendziorra H, Pressler H. Long-term prognosis of focal sclerosis glomerulonephritis. A analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990; 33: 115-122
30. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Muller CA, Muller GA. The pathogenesis of chronic renal failure in diabetic nephropathy: investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 1991; 187: 251-259
31. Mackensen-Haen R, Eissele R, Bohle A. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis. Lab Invest 1988; 59: 239-244
32. Wehrmann M, Bohle A, Bogenschutz O et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. Clin Nephrol 1989; 31: 67-76
33. Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlation in renal disease II. The correlations. Hum Pathol 1970; 1: 631-641
34. Mackensen-Haen S, Bohle A, Christensen J, Wehrmann M, Kendziorra H, Kokot F. The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992; 37: 70-77
35. Maack T, Park CH, Camargo MJF. Renal filtration, transport, and metabolism of proteins. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. Raven Press, New York, 1985: 1773-1803
36. Brunskill NJ, Cockcroft N, Nahorski S, Walls J. Albumin endocytosis is regulated by heterotrimeric GTP-binding protein Gα1-3 in opossum kidney cells. Am J Physiol 1996; 271: F356-364
37. Cessac-Guillemet AL, Mounier F, Borot C et al. Characterization and distribution of albumin binding protein in normal rat kidney. Am J Physiol 1996; 271: F101-107
38. Cui S, Verroust PJ, Moestrup SK, Christensen EI. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol 1996; 271: F900-907
39. Haymann J-P, Bouet S, Levraud J-P et al. Characterization of the neonatal Fc receptor (FcRn) on cultured human glomerular epithelial cells. Localization of FcRn in normal human kidney. J Am Soc Nephrol 1997; 8: 456A (Abstract)
40. Olbricht CJ, Cannon JK, Garg LC, Tisher CC. Activities of cathepsin B and L in isolated nephron segments from proteinuric and non proteinuric rats. Am J Physiol 1986; 250: F1055-1062
41. Zager RA, Schimpf BA, Bredl CR, Gmur DJ. Inorganic iron effects on in vitro hypoxic proximal tubular cell injury. J Clin Invest 1993; 91: 702-708
42. Harris DCH, Chen L, Tay C, Chen J, Nankivell BJ. Cytotoxicity of reabsorbed protein in proximal tubule (PT) by peroxidation. J Am Soc Nephrol 1994; 5: 944 (Abstract)
43. Hirschberg R. Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions. J Clin Invest 1997; 98: 116-124
44. Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994; 45: 1697-1709
45. Schreiner GF. Renal toxicity of albumin and other lipoproteins. Curr Opin Nephrol Hypertens 1995; 4: 369-373
46. Nomura A, Morita Y, Maruyama S et al. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol 1997; 151: 539-547
47. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9: 1213-1224
48. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA. In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 1982; 128: 1659-1663
49. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994; 45: 451-460
50. 1, Camussi G. Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 1997; 12: 51-56
51. Bürger A, Hug F, Hänsch GM. Stimulation of human tubular epithelial cells in culture (TEC) by complement C5b-9. Exp Nephrol 1998; 6: 165 (Abstract)
52. Brooimans RA, Stegmann APA, van Dorp WT et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991; 88: 379-384
53. Abbate M, Bertani T. New insights into the pathogenesis of tubulointerstitial damage. In: Tetta C, ed. Immunopharmacology of the Renal System. Academic Press, London, 1993; 21-34
54. Abbate M, Zoja C, Rottoli D et al. ACE-inhibition protects rats with reduction of renal mass (RMR) against tubular complement deposition and interstitial inflammation. J Am Soc Nephrol (in press) (Abstract)
55. Benigni A, Abbate M, Gagliardini E et al. In rats with renal mass reduction (RMR) protein-dependent interstitial accumulation of T-cells and macrophages is limited by antiproteinuric drugs. J Am Soc Nephrol (in press) (Abstract)
56. Eddy AA. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 1996; 49 [Suppl. 54]: S49-54
57. Harris DCH, Chen J. Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in response to protein in rat proximal tubule cells in culture. J Am Soc Nephrol 1995; 6: 1015 (Abstract)
58. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675-705
59. Tang WW, Qi M, Warren JS, Van GY. Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 1997; 159: 870-876
60. Zoja C, Donadelli R, Colleoni S et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 1998; 53: 1608-1615
61. Lloyd CM, Minto AW, Dorff ME et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185: 1371-1380
62. Fujihara CK, Maiheiros DMAC, Oliveira SG, Antunes SG, Zatz R, Noronha IL. Mycophenolate mofetil attenuates renal injury in the remnant kidney. J Am Soc Nephrol 1997; 8: 615A (Abstract)
63. Romero F, Parra G, Rodriguez-Iturbe B, Gonzalez L. Mycophenolate mofetil (MMF) prevents the renal damage induced by 5/6 nephrectomy (Nx) in the rat. J Am Soc Nephrol 1997; 8: 628A
64. Zoja C, Corna D, Benigni A et al. The effect of lisinopril, mycophenolate mofetil (MMF) and their combination on renal disease progression in rats with remnant kidney (RMR). J Am Soc Nephrol (in press) (Abstract)
65. Sharma K, Ziyadeh FN. The transforming growth factor-β system and the kidney. Semin Nephrol 1993; 13: 116-128
66. Benigni A, Remuzzi G. The renoprotective potential of endothelin receptor antagonists. Exp Opin Ther Patents 1997; 7: 139-149
67. Zoja C, Morigi M, Figliuzzi M et al. proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995; 26: 934-941
68. Ong ACM, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG. A new paracrine loop implicated in human tubulointerstitial fibrosis: tubular-derived endothelins modulate renal interstitial fibroblast function. J Am Soc Nephrol 1993; 4: 473 (Abstract)
69. Nakamura T, Ebihara I, Fukui M et al. Renal expression of mRNAs for endothelin-1, endothelin-3and endothelin receptors in NZB/W F1 mice. Renal Physiol Biochem 1993; 16: 233-243
70. Theuring F, Schmager F, Thone-Reinicke C et al. Transgenic mice in endothelin research. Fourth International Conference on Endothelin, London 23-26 April 1995; 146 (Abstract)
71. Hocher B, Liefeldt L, Thone-Reineke C et al. Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene. Hypertension 1996; 28: 196-201
72. Zoja C, Liu X-H, Abbate M et al. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy. Exp Nephrol 1998; 6: 121-131
73. Barnes PJ, Karin M. Nuclear factor-κB - A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 356: 1066-1071
74. Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. J Am Soc Nephrol (in press)
75. Morita Y, Nomura A, Yuzawa Y et al. The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1997; 8: 1363-1372
76. Peruzzi L, Trusolino L, Amore A et al. Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates αVβ5 integrin. Kidney Int 1996; 50: 1310-1320
77. Orisio S, Benigni A, Bruzzi I et al. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993; 43: 354-358
78. Zoja C, Corna D, Bruzzi I et al. Passive Heymann Nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 1996; 4: 213-221